Revenue
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Accendra Health Inc (ACH)
Price$1.21Cached quote
Net income
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.76B | $2.68B | $2.55B | $9.96B | $9.79B | $8.48B | $9.21B | $9.42B | $9.32B | $9.72B | $9.77B | $9.44B | $9.07B | $8.87B | $8.63B | $8.12B | $8.04B | $7.24B |
| Gross profit | $1.29B | $2.22B | $2.13B | $1.83B | $1.51B | $1.28B | $1.13B | $1.07B | $1.17B | $1.19B | $1.21B | $1.17B | $1.12B | $924.7M | $857.5M | $807.7M | $814.4M | $741.1M |
| Gross margin | 46.68% | 82.80% | 83.26% | 18.35% | 15.46% | 15.10% | 12.25% | 11.37% | 12.58% | 12.21% | 12.43% | 12.39% | 12.31% | 10.43% | 9.94% | 9.94% | 10.13% | 10.23% |
| Research & development | — | $13.0M | $13.0M | $12.0M | $12.1M | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating expenses | $2.73B | $2.90B | $2.42B | $1.68B | $1.14B | $1.08B | $1.06B | $1.42B | $1.08B | $987.7M | $1.01B | $1.01B | $919.0M | $727.9M | $654.0M | $611.8M | $613.1M | $560.4M |
| Operating income | $27.5M | −$217.7M | $133.2M | $142.9M | $368.5M | $204.1M | $73.2M | −$352.3M | $89.3M | $199.6M | $200.4M | $159.5M | $198.1M | $196.8M | $203.5M | $195.9M | $201.3M | $180.7M |
| Operating margin | 0.99% | −8.12% | 5.22% | 1.44% | 3.77% | 2.41% | 0.79% | −3.74% | 0.96% | 2.05% | 2.05% | 1.69% | 2.18% | 2.22% | 2.36% | 2.41% | 2.50% | 2.50% |
| EBITDA | $242.0M | −$36.4M | $343.6M | $371.6M | $459.1M | $297.5M | $189.8M | −$250.4M | $148.7M | $255.0M | $266.3M | $222.9M | $248.7M | $236.4M | $237.7M | $225.1M | $226.5M | $202.7M |
| EBITDA margin | 8.76% | −1.36% | 13.46% | 3.73% | 4.69% | 3.51% | 2.06% | −2.66% | 1.60% | 2.62% | 2.73% | 2.36% | 2.74% | 2.67% | 2.75% | 2.77% | 2.82% | 2.80% |
| Net income | −$1.10B | −$362.7M | −$41.3M | $22.4M | $221.6M | $29.9M | −$62.4M | −$437.0M | $72.8M | $108.8M | $103.4M | $66.5M | $110.9M | $109.0M | $115.2M | $110.6M | $104.7M | $93.3M |
| Net profit margin | −39.85% | −13.53% | −1.62% | 0.22% | 2.26% | 0.35% | −0.68% | −4.64% | 0.78% | 1.12% | 1.06% | 0.70% | 1.22% | 1.23% | 1.34% | 1.36% | 1.30% | 1.29% |
| Basic EPSper basic share | -$14.31 | -$4.73 | -$0.54 | $0.30 | $3.05 | $0.47 | -$1.03 | -$7.28 | $1.20 | $1.76 | $1.65 | $1.06 | $1.76 | $1.72 | $1.82 | $1.76 | $1.68 | $1.01 |
| Diluted EPSper diluted share | -$14.31 | -$4.73 | -$0.53 | $0.29 | $2.94 | $0.47 | -$1.03 | -$7.28 | $1.20 | $1.76 | $1.65 | $1.06 | $1.76 | $1.72 | $1.81 | $1.75 | $1.67 | $1.00 |
Owners
Reported shareholders
17.04%of listed shares
Coliseum Capital Management, LLC13.1M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
Coliseum Capital Management, LLC | 17.04%13.1M shares |
BlackRock, Inc. | 7.16%5.5M shares |
BANK OF AMERICA CORP /DE/ | 4.91%3.78M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 4.02%3.09M shares |
D. E. Shaw & Co., Inc. | 4.01%3.08M shares |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3.76%2.89M shares |
Invenomic Capital Management LP | 3.66%2.81M shares |
MARSHALL WACE, LLP | 3.36%2.58M shares |
PARADIGM CAPITAL MANAGEMENT INC/NY | 3.30%2.54M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 2.64%2.03M shares |
Dana Investment Advisors, Inc. | 2.53%1.94M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.44%1.87M shares |
DIMENSIONAL FUND ADVISORS LP | 2.13%1.64M shares |
STATE STREET CORP | 2.08%1.6M shares |
Connor, Clark & Lunn Investment Management Ltd. | 1.68%1.29M shares |
Pesicka Edward A | ≈1.39%1.07M shares |
AQR CAPITAL MANAGEMENT LLC | 1.39%1.07M shares |
GOLDMAN SACHS GROUP INC | 1.11%854.73K shares |
ACADIAN ASSET MANAGEMENT LLC | 1.07%820.07K shares |
TWO SIGMA INVESTMENTS, LP | 0.93%718.55K shares |
Percentages use 76.91M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Aug 14, 2025Form 4 | COLISEUM CAPITAL PARTNERS, L.P. +4TenPercentOwner | BuyCommon Stock · indirect | 492.9K | $5.31 | $2.62M | 13.10M |
| Aug 13, 2025Form 4 | COLISEUM CAPITAL PARTNERS, L.P. +4TenPercentOwner | BuyCommon Stock · indirect | 325.0K | $5.46 | $1.77M | 12.61M |
| Aug 12, 2025Form 4 | COLISEUM CAPITAL PARTNERS, L.P. +4TenPercentOwner | BuyCommon Stock, par value $2 per share ("Common Stock") · indirect | 720.0K | $5.15 | $3.71M | 12.28M |
| Apr 10, 2025Form 4 | Coliseum Capital, LLC +4TenPercentOwner | BuyCommon Stock · indirect | 80.0K | $7.19 | $575.2K | 11.56M |
| Apr 9, 2025Form 4 | Coliseum Capital, LLC +4TenPercentOwner | BuyCommon Stock · indirect | 225.0K | $7.39 | $1.66M | 11.48M |